Rankings
▼
Calendar
XENE FY 2020 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
XENE
Xenon Pharmaceuticals Inc.
$5B
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$32M
+371.0% YoY
Gross Profit
$32M
100.0% margin
Operating Income
-$31M
-97.3% margin
Net Income
-$29M
-89.7% margin
EPS (Diluted)
$-0.83
Cash Flow
Operating Cash Flow
-$48M
Free Cash Flow
-$51M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$189M
Total Liabilities
$18M
Stockholders' Equity
$171M
Cash & Equivalents
$45M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$32M
$7M
+371.0%
Gross Profit
$32M
$7M
+371.0%
Operating Income
-$31M
-$43M
+26.9%
Net Income
-$29M
-$42M
+30.7%
← Q4 2019
All Quarters
Q1 2020 →